Value. integrity. partnership.
Addressing Unique Challenges That Global Companies Face
We help you develop effective regulatory strategies, design robust quality systems, and implement sustainable processes that yield successful outcomes.
We accelerate time to approval and reduce time to market utilizing a risk-based approach to identify gaps and achieve successful, scalable outcomes.
Upskilling and Education
We offer innovative education platforms and a unique "Twinning" mentorship process which ensures you understand the "why" and leads to long-term success.
Deep Experience Matters
Our team of more than 350 technical and operational leaders, each with an average of 27 years of global pharma experience, streamlines the process of identifying and solving your scientific, quality, and manufacturing challenges.
Your team can rely on our industry thought leaders who are deeply experienced in leading and teaching for the world's premier pharma trade organizations.
Creating Roadmaps to the Future for Pharma
Our team possesses unrivaled experience in the regulatory landscape around the globe. We see around corners to what's next in evolving practices like cell and gene therapy. When "you don't know what you don't know," and you're trying to launch your company or product in a novel space, QxP is here.QxP Capabilities
A Partner Committed to Your Long-Term
We listen to your needs and create tailored strategies and plans.
Our experts partner with you to implement pragmatic solutions.
We educate your leaders and provide robust processes and tools to ensure your sustainability.
Commercialization Starts Here
We help you take your cell therapy product from breakthrough to blockbuster.
The QxP operating model drives novel life science products to market through a pragmatic approach to GxPs.
We position you for risk-reduced operational growth.
What makes QxP unique is their expert talent & ability to augment your organization to accomplish your business objectives. They leave your organization stronger. I cannot recommend QxP highly enough.”
Scott Canute, former President Global Manufacturing Eli Lilly and Company and Genzyme Corp., Current Executive Board Director Immunomedics, Inc.
Thank goodness we've had QxP present at (the site) for the past month. We are much better prepared now than we ever would have been on our own. We are not only aware of the issues, but your recommendations for addressing them have been spot on.”
Head of Global Compliance for a Global Company Speaking About a Warning Letter Remediation Support Program
The selection of QxP as the third party expert for our Warning Letter remediation was the best decision we made.”
Senior VP of Operations for a Global Pharmaceutical Company